Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A pediatric oncology group study

Leukemia and Lymphoma

Volumn 31, Issue 5-6, 1998, Pages 507-519

  Whitehead, V M ^a,b,o   Vuchich, M J ^a   Cooley, L D ^c   Lauer, S J ^d   Mahoney, D H ^e   Shuster, J J ^f   Payment, C ^a   Koch, P A ^b   Akabutu, J J ^g   Bowen, T ^g   Kamen, B A ^h   Ravindranath, Y ⁱ   Emami, A ^j   Look, A T ^k,l   Beardsley, G P ^m   Pullen, D J ⁿ   Camitta, B ^d  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TEXAS   (United States)

^d The Medical College of Wisconsin and Children's Hospital of Wisconsin   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f University of Florida   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^k ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^l UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^o MONTREAL CHILDREN S HOSPITAL   (Canada)

more..

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Hyperdiploidy; Methotrexate; Polyglutamates

Indexed keywords

METHOTREXATE; METHOTREXATE POLYGLUTAMATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CHROMOSOME 10; CHROMOSOME 4; DRUG ACCUMULATION; HUMAN; HUMAN CELL; LYMPHOBLAST; MAJOR CLINICAL STUDY; NUMERICAL CHROMOSOME ABERRATION; PLOIDY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION; TRISOMY;

EID: 0032449896     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057610     Document Type: Article

References (53)

1. Niemeyer, C. M., Hitchcock-Bryan, S., and Sallan, S. E. (1985) Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Sem. Oncol., 12, 122-130.
2. Pinkel, D. (1987) Curing children of leukemia. Cancer, 59, 1683-1691.
3. Rivera, G. K., Mauer, A. M. (1987) Controversies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors. Sem. Hematol., 24, 12-26.
4. Craft, A. W., Rankin, A., Aherne, W. (1981) Methotrexate absorption in children with acute lymphoblastic leukemia. Cancer Treatment Report, 65, 77-81.
5. Balis, F. M., Savitch, J. L., Bleyer, W. A. (1983) Pharmacokinetics of oral methotrexate in children. Cancer Res., 43, 2342-2345.
6. Evans, W. E., Crom, W. R., Abromowitch, M., Dodge, R., Look, A. T., Bowman, W. P., George, S. L., Pui, C-H. (1986) Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. New Engl. J. Med., 314, 471-477.
7. Shane, B. (1989) Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitamins Hormones, 45, 263-335.
8. Rosenblatt, D. S., Whitehead, V. M., Vera, N., Pottier, A., Dupont, M., Vuchich, M-J. (1978) Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured cells. Mol. Pharmacol., 14, 1143-1147.
9. Galivan, J. (1980) Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. Mol. Pharmacol., 17, 105-110.
10. Fry, D. W., Yalowich, J. C., Goldman, I. D. (1982) Rapid formation of polygammaglutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high-pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J. Biol. Chem. 257:1890-1896.
11. 5 to dihydrofolate reductase. J. Clin. Invest. 72:773-778.
12. Whitehead, V. M. (1977). Synthesis of methotrexate polyglutamates in murine L1210 leukemia cells. Cancer Res. 37:408-412.
13. 10-methylpteroyl-glutamyl-γ-glutamate. Biochem. Biophys. Res. Commun. 63:692-698.
14. Kisliuk, R. L., Gaumont, Y., Baugh, C. M., Galivan, J. M., Maley, G. F., Maley, F. (1979). Inhibition of thymidylate synthetase by poly-γ-glutamyl derivatives of folic acid and methotrexate, In Chemistry and Biology of Pteridines. R.L. Kisliuk, and G.M. Brown, editors. New York, NY, Elsevier/North Holland, p. 431-435.
15. Allegra, C. J., Chabner, B. A., Drake, J. C., Lutz, R., Rodbard, D. (1985). Enhanced inhibition of thymidylate synthetase by methotrexate polyglutamates. J. Biol. Chem. 260:9720-9726.
16. Allegra, C. J., Drake, J. C., Jolivet, J., Chabner, B. A. (1985). Inhibition of phosphoribosyl-aminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc. Natl. Acad. Sci. USA 82:4881-4885.
17. Fischer, G. A. (1962). Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. Biochem. Pharmacol. 11:1233-1234.
18. Trippett, T., Schlemmer, S., Elisseyeff, Y., Goker, E., Wachter, M., Steinherz, P., Tan, C., Berman, E., Wright, J. E., Rosowsky, A., Schweitzer, B., Bertino, J. R. (1992). Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood 80:1158-1162.
19. Alt, F. W., Kellems, R. E., Bertino, J. R., Schimke, R. T. (1978). Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J. Biol. Chem. 253:1357-1370.
20. Goldie, J. H., Krystal, G., Hartley, D., Gudauskas, G., Dedhar, S. (1980). A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells. Eur. J. Cancer 16:1539-1546.
21. Flintoff, W. F., Essani, K. (1980). Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochem. 19:4321-4327.
22. Horns, R., Dower, W. J., Schimke, R. T. (1984). Gene amplification in a leukemic patient treated with methotrexate. J. Clin. Oncol. 2:2-8.
23. Carman, M. D., Schornagel, J. H., Rivest, R. S., Srimatkandada, S., Portlock, C. S., Bertino, J. R. (1984). Resistance to methotrexate due to gene amplification in a patient with acute leukemia. J. Clin. Oncol. 2:16-21.
24. Cowan, K. H., Jolivet, J. (1984). A methotrexate-resistant human breast cancer cell line with multiple defects including diminished formation of methotrexate polyglutamates. J. Biol. Chem. 259:10793-10800.
25. Pizzorno, G., Mini, E., Coronello, M., McGuire, J. J., Moroson, B. A., Cashmare, A. R., Dreyer, R. N., Lin, J. T., Mazzei, T., Periti, P., Bertino, J. R. (1988). Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. Cancer Res. 48:2149-2155.
26. Whitehead, V. M., Rosenblatt, D. S., Vuchich, M-J., Beaulieu, D. (1987). Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia. Dev. Pharmacol. Ther. 10:443-448.
27. Koizumi, S., Curt, G. A., Fine, R. L., Griffin, J. D., Chabner, B. A. (1985). Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow. J. Clin. Invest. 75:1008-1014.
28. Whitehead, V. M., Rosenblatt, D. S., Vuchich, M-J., Shuster, J. J., Witte, A., Beaulieu, D. (1990). Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: A pilot prognostic factor analysis. Blood 76:44-49.
29. Whitehead, V. M., Vuchich, M-J., Lauer, S. J., Mahoney, D., Carroll, A. J., Shuster, J. J., Esseltine, D. W., Payment, C., Look, A. T., Akabutu, J., Bowen, T., Taylor, L. D., Camilla, B., Pullen, D. (1992). Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (> 50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Blood 80:1316-1323.
30. Synold, T. W., Relling, M. V., Boyett, J. M., Rivera, G. K., Sandlund, J. T., Mahmoud, H., Crist, W. M., Pui, C-H., Evans, W. E. (1994). Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J. Clin. Invest. 94:1996-2001.
31. Masson, E., Relling, M.V., Synold, T.W., Liu, Q., Schuetz, J.D., Sandlund, J.T., Pui, C-H., Evans, W.E. (1996). Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. J. Clin. Invest., 97:73-80.
32. Trueworthy, R., Shuster, J., Look, T., Crist, W., Borowitz, M., Carroll, A., Frankel, L., Harris, M., Wagner, H., Haggard, M., Mosijczuk, A., Pullen, J., Steuber, P., Land, V. (1992). Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J. Clin. Oncol. 10:606-613.
33. Harris, M. B., Shuster, J. J., Carroll, A., Look, A. T., Borowitz, M. J., Crist, W. M., Nitschke, R., Pullen, J., Steuber, C. P., Land, V. J. (1992). Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 79:3316-3324.
34. Crist, W. M., Carroll, A. J., Shuster, J. J., Behm, F. G., Whitehead, M., Vietti, T. J., Look, A. T., Mahoney, D., Ragab, A., Pullen, D. J., Land, V. J. (1990). Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group study. Blood 76:117-122.
35. Look, A. T., Melvin, S. L., Williams, S. L., Brodeur, G. M., Dahl, G. V., Kalwinsky, D. K., Murphy, S. B., Mauer, A. M. (1982). Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood 60:959-967.
36. Lehmann, E. L. (1975). Nonparametrics: Statistical methods based on ranks. Holden-Day, San Francisco, CA: Chapter 7.
37. Lehmann, E. L. (1975). Nonparametrics: Statistical methods based on ranks. Holden-Day, San Francisco, CA. Chapter 2.
38. Jones C, Kao F-T, Taylor RT (1980). Chromosomal assignment of the gene for folylpolyglutamate synthetase to human chromosome 9. Cytogenet. Cell Genet. 28 :181-194.
39. Manabe, A., Coustan-Smith, E., Behm, F.G., Raimondi, S.C., Campana, D. (1992). Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79:2370-2377.
40. Lenz, H-J., Danenberg, K., Schneiders, B., Goeker, E., Peters, G. J., Garrow, T., Shane, B., Bertino, J. R., Danenberg, P. V. (1994). Quantitative analysis of folylpolyglutamate synthetase expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemic patients. Oncol. Res. 6 :329-335.
41. Barredo, J. C., Synold, T. W., Laver, J., Relling, M. V., Pui, C-H., Priest, D. G., Evans, W. E. (1994). Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood 84:564-569.
42. Prasad, P. D., Ramamoorthy, S., Leibach, F. H., Ganapathy, V. (1995). Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun 206:681-687.
43. Williams, F. M., Flintoff, W. F. (1995). Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol Chem 270:2987-2992.
44. Wong, S. C., Proefke, S. A., Bhushan, A., Matherly, L. H. (1995). Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J. Biol. Chem., 270: 17468-75.
45. Moscow, J. A., Gong, M., He, R., Sgagias, M. K., Dixon, K. H., Anzick, S. L., Meltzer, P. S., Cowan, K. H. (1995). Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55: 3790-3794.
46. Yao, R., Schneider, E., Ryan, T. J., Galivan, J. (1996). Human γ-glutamyl hydrolase: Cloning and characterization of the enzyme expressed in vitro. Proc. Natl. Acad. Sci. (USA), 93: 1904-1908.
47. Garre, M. L., Relling, M. V., Kalwinsky, D., Dodge, R., Crom, W. R., Abromowitch, M., Pui, C.-H., Evans, W. E. (1987). Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. J. Pediatr 111:606-612.
48. Whitehead, V. M., Vuchich, M.-J., Cooley, L. D., Lauer, S. J., Mahoney, D., Shuster, J. J., Payment, C., Bernstein, M. L., Akabutu, J. J., Bowen, T., Kamen, B. A., Watson, M. S., Look, A. T., Pullen, D. J., Camitta, B. (1998). Translocations involving chromosome 12p11-13, methotrexate metabolism and outcome in childhood B-lineage acute lymphoblastic leukemia (ALL). Clin. Cancer Res., 4:183-188.
49. Raimondi, S. C., Pui, C.-H., Hancock, M. L., Behm, F. G., Filatov, L., Rivera, G. K. (1996). Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10:213-224.
50. Brodeur, G. M., Nakagawara, A. (1992). Molecular basis of clinical heterogeneity in neuroblastoma. [Review]. Am. J. Ped. Hemat. Oncol. 14:111-116.
51. Thompson, M. W., McInnes, R. R., Willard, H. F. (1991). Genetics in Medicine, 5th Edition. W.B. Saunders Co., Philadelphia. 201-229 pp.
52. Onodera, N., McCabe, N. R., Rubin, C. M. (1992). Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 80:203-208.
53. Kaspers, G. J. L., Smets, L. A;., Pieters, R., Van Zantwijk, C. H., Van Wering, E. R., Veerman, A. J. P. (1995). Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study. Blood 85:751-756.